BRACCO TRIPLES PRODUCTION OF ITS INNOVATIVE CONTRAST AGENT FOR ULTRASOUND IN GENEVA, INAUGURATING A SECOND FACILITY | PR Newswire [Video]

The significant investment increases the production of CEUS microbubbles

The imaging platform for ultrasound, the fruit of Bracco’s research, assists doctors all over the world with more accurate diagnostic data, improving patients’ quality of life and facilitating personalized treatment plans

, /PRNewswire/ — Over 80 million euros have been invested to build Hexagon, a new manufacturing facility located next to the historical 1997 plant which will, when fully operational, triple the production and distribution of one of the leading products from Bracco’s research. The new multi-functional building will supply the world with the innovative contrast agent for ultrasound based on microbubbles, which allows real-time diagnosis and offers greater versatility as well as sustainability. It is the latest milestone in the Bracco Group’s long-standing story of success. Founded in Milan in 1927, today the company operates in 100 countries while maintaining its strong Italian roots, and counts 1.8 billion euros in turnover and over 3,800 employees.

The ties with Switzerlandgo back a long way: first the Research Center, nearly 40 years ago, …